Biogen Inc. (FRA:IDP)
155.30
-2.95 (-1.86%)
At close: Nov 28, 2025
Biogen Employees
Biogen had 7,605 employees as of December 31, 2024. The number of employees increased by 35 or 0.46% compared to the previous year.
Employees
7,605
Change (1Y)
35
Growth (1Y)
0.46%
Revenue / Employee
€1,128,096
Profits / Employee
€180,266
Market Cap
23.04B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7,605 | 35 | 0.46% |
| Dec 31, 2023 | 7,570 | -1,155 | -13.24% |
| Dec 31, 2022 | 8,725 | -885 | -9.21% |
| Dec 31, 2021 | 9,610 | 510 | 5.60% |
| Dec 31, 2020 | 9,100 | 1,700 | 22.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Biogen News
- 17 days ago - STATE STREET CORP Reduces Stake in Biogen Inc: A Detailed Analysis - GuruFocus
- 17 days ago - Biogen Completes Acquisition of Alcyone Therapeutics - GlobeNewsWire
- 17 days ago - Biogen (BIIB) Gains UK Approval for LEQEMBI Maintenance Dosing - GuruFocus
- 18 days ago - Biogen Inc. (BIIB) Presents at TD Cowen Immunology and Inflammation Summit Transcript - Seeking Alpha
- 18 days ago - “LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Approved in the United Kingdom - GlobeNewsWire
- 18 days ago - What the Options Market Tells Us About Biogen - Benzinga
- 21 days ago - Biogen Inc. (BIIB) Presents at Wedbush Rewind ASN 2025 Conference Prepared Remarks Transcript - Seeking Alpha
- 25 days ago - Stifel Upgrades Biogen (BIIB) to 'Buy', Raises Price Target to $202 | BIIB Stock News - GuruFocus